ANN ARBOR, MI - Sept. 25, 2020 - The Extracorporeal Life Support
Organization (ELSO) announced today publication in The Lancet of registry findings examining the
treatment of COVID-19 patients with extracorporeal membrane oxygenation (ECMO) support. The results show that
for ECMO-supported patients with COVID-19, estimated in-hospital mortality 90 days after ECMO and mortality
rates in those with a final disposition of death or discharge were under 40 percent.
Full Press Release
The Lancet Article
FULL COVID-19 REGISTRY
The Dashboard content has been compiled and reported from a variety of sources, is not independently
verified by ELSO, and is subject to change without notice. ELSO and its authorized agents and contractors
make no representations or warranties about the quality, content, completeness, suitability, adequacy,
sequence, accuracy, or timeliness of such content. ELSO disclaims any responsibility for any inaccuracy,
whether by inclusion or omission, on the Dashboard or the Site, and disclaims any responsibility for
subsequent change or withdrawal of data shown on the Dashboard or the Site, which is subject to alteration
without notice. ELSO disclaims any and all warranties regarding this information and all liability
whatsoever relating thereto. Any person who uses information obtained from this Dashboard does so at his or
her own risk.
The Dashboard is provided as a public service to facilitate real-time sharing of information during the
COVID-19 crisis for educational purposes only by health practitioners. ELSO owns the compilation of all
data, and its use or publication by any third party is strictly forbidden. Publication or representation of
this information as if it were statistically significant or part of a scientific study is irresponsible and
Tweets by ELSO
The Extracorporeal Life Support Organization (ELSO) is an international non-profit consortium of health care
institutions who are dedicated to the development
and evaluation of novel therapies for support of failing organ systems. Crucial is the promotion of a broad
multidisciplinary collaboration. The primary mission of
the Organization is to maintain a registry of, at least, use of extracorporeal membrane oxygenation in active
ELSO centers. As appropriate, registries of other novel
forms of organ system support are within the purview of ELSO. Registry data is to be used to support clinical
research, support regulatory agencies, and support
individual ELSO centers. ELSO provides educational programs for active centers as well as for the broader
medical and lay communities.
Please plan on attending ELSO's 32nd annual meeting September 30th to October 1st. Registration will be opening soon. Abstract submission open - deadline is July 15th. Details on the meeting page.
Please use the below link to view upcoming deadlines for the ELSO Registry.
July 10, 2021 - Deadline to submit data for inclusion in upcoming Registry Freeze.
Due to the worldwide COVID pandemic the deadline for Award of Excellence applications has been extended to June 1, 2021.
For more information
Please update your records with ELSO's updated mailing address:
3001 Miller Rd
Ann Arbor, MI, 48103 USA
ELSO has prepared an in-depth set of guidelines for ECMO in COVID-19 patients. These have been collaboratively developed by a global team of ECMO experts. The guidelines include: patient selection criteria, cannulation and decannulation strategies, transport on ECMO, PPE and staff protection strategies with ECMO, to ethical dilemmas and quality. ELSO wants to recognize the leadership of Kiran Shekar in chairing the development of these guidelines during a critical time.
Guidelines for ECMO in COVID-19 patients Link
ELSO has developed a map that quickly shows ECMO capacity (map: https://www.elso.org/Membership/CenterMap.aspx). Center administrators can update the capacity here: http://www.elso.org/UpdateECMOCapacity) or from the Manage - Manage Center Details section.
Join the discussion and begin fostering
communication and collaboration among
professionals who apply advanced technologies
in the treatment of refractory organ failure
32nd Annual ELSO Conference
09/30/2021 - 10/01/2021
Posted Date: 05/26/2020
APELSO 2021 Meeting
10/28/2021 - 10/31/2021
Location: Taipei, Taiwan
Ms. Molly Hsiao +886-2-2798-8329 ext. 18 firstname.lastname@example.org
Posted Date: 02/08/2021
10th EuroELSO Congress
05/04/2022 - 05/06/2022
Location: London, UK
Posted Date: 06/10/2021
Adult ECMO for respiratory failure and septic shock
10/11/2021 - 10/14/2021
Location: Stockholm, Sweden
Björn Frenckner +46707226115 email@example.com
Posted Date: 03/12/2021
© Copyright Site Map
• Contact Us
• Report Bug
This website designed and maintained by IGD Solutions Corporation